Research Funding
What’s at risk
Harvard is home to the world’s most cutting-edge medical, scientific, and technological research. For decades, that research has been supported by the federal government, among many other sponsors. That support is essential for the continuation of groundbreaking innovations that impact countless human lives.
Without federal funding, this work will come to a halt midstream, and researchers will lack necessary resources to finish ongoing projects or to finance new ones in the numerous fields Harvard supports, including:
The National Cancer Institute estimates more than 17 million people in the U.S. were living with cancer of any site in 2021, and nearly 40% of men and women will be diagnosed with cancer during their lifetime.
A form of cancer immunotherapy called checkpoint blockade developed by HMS scientists is currently used for the treatment of at least 12 types of cancer. Hundreds of thousands of patients with cancer stand to benefit from these therapies each year, according to estimates.
- A first-in-class drug to treat a form of blood cancer known as multiple myeloma
- Research Pinpoints Weakness in Lung Cancer’s Defenses
- Study Finds Three New Safe, Effective Regimens to Treat Drug-Resistant Tuberculosis
- Why Do Fatal Brain Tumors Recur in the Brain?
- Optimizing current cancer immunotherapy to design new treatments that boost the efficacy of cancer immunotherapy among patients who don’t respond well.
- How certain cancers subvert the immune system and help tumors grow
Devices that regulate heart rhythm and shock the heart out of lethal arrythmias to prevent sudden cardiac death—which the CDC estimates affects 356,000 people in the U.S. each year, while some 200,000 heart-rhythm regulating pacemakers are implanted each year in the U.S.
The NIH Genetic and Rare Diseases Information Center estimates 5,000 people in the U.S. have Huntington disease, and the Association for Frontotemporal Degeneration estimates 60,000 cases of FTD in the U.S.
The CDC estimates that one in 10 Americans, or between 34 and 36 million people, have type 2 diabetes; obesity is estimated to affect about one billion people globally. A Harvard Medical School researcher discovered glucagon-like peptide-1 (GLP-1), a molecule that has become the basis for the therapies that have revolutionized obesity treatment. Additional discoveries enabled the design of disease-altering therapies for type 2 diabetes.
The CDC estimates there were 10.2 million visits to physician offices in 2019 and 3.8 million emergency department visits in 2021 for infectious and parasitic diseases.
The Organ Procurement and Transplantation Network, part of the Health Resources & Services Administration, estimates 89,792 patients were on the waiting list for a kidney transplant in September 2024, and the CDC estimates more than 35.5 million people are living with chronic kidney disease in the U.S.
A team at Massachusetts General Hospital led by Harvard Medical School physician-scientists successfully transplanted a genetically edited pig kidney into a living person. The team performed the first surgery of its kind in the world, with the ultimate goal to alleviate critical organ shortages around the world.
Photo at right: 66-year-old New Hampshire resident Tim Andrews, is the fourth person in the world to receive a pig kidney and one of two people currently living with one.
“It’s through research that we can live longer, healthier lives.”
Harvard scientists discuss potential impacts of federal funding cuts — from U.S. brain drain to fewer medical breakthroughs.
Funding cuts to Harvard have a broad impact
Funding cuts to Harvard reverberate far beyond our campus. Each year, Harvard researchers partner with universities and hospitals across the country to utilize their expertise, gain new perspectives, and collaborate on solutions.
Recent funding cuts have impacted dozens of hospitals, universities, and research institutions across 32 states, from Morehouse School of Medicine to Cincinnati Children’s Hospital to Texas Biomedical Research Institute.
By the numbers
Federal funding is the University’s largest source of support for research, playing a pivotal role in enabling studies that deliver widespread societal benefits. More than one third of research carried out at Harvard is funded directly by the University.
-
402
Innovations reported by Harvard researchers in the 2024 fiscal year
-
155
U.S. patents issued in 2024
-
162
Number of Harvard Nobel laureates, including one from 2024
-
$1 billion
research funding from a combination of federal, foundation, and industry sponsors in 2024
-
$526 million
Research funded directly by the University in 2024
The history of federal funding and the real-world price if it’s halted
For 75 years, the federal government has partnered with academic institutions, fueling discoveries that have transformed medicine, saved lives, and positioned the United States as a global science leader. If this funding is halted it interrupts work on tuberculosis, chemotherapy, pandemic preparedness, Parkinson’s disease, and Alzheimer’s disease.
Federal funding freeze leaves grad students, postdocs scrambling for labs, support
Deadly Cost of Funding Cuts
Trump administration’s escalating feud with Harvard affects breast cancer research
Scores of Researchers Receive Termination Notices After Federal Government Cuts Most Grants to Harvard
He got the stop-work order. Then the scrambling began.
Antisemitism and Research Funding
The government claims to have taken this action because it says the University has not fulfilled its obligations to curb and combat antisemitic harassment.
Harvard continues to devote considerable effort to addressing antisemitism. We have strengthened our rules and our approach to disciplining those who violate them. We have enhanced training and education on antisemitism across our campus and introduced measures to support our Jewish community and ensure student safety and security. We have launched programs to promote civil dialogue and respectful disagreement inside and outside the classroom. We have adopted many other reforms, and we will continue to combat antisemitism and to foster a campus culture that includes and supports every member of our community. Curtailing research funding, however, will not help with this important work. What it will do is jeopardize lifesaving cures as well as work that ensures our nation’s economic and defense security.
- Documents
Final Judgment
Judgment for Harvard ruling that the termination of research funding be vacated and set aside.
- In the Media
Trump slashed funding for universities that helped create these vital drugs
- In the Media
After funding halt, Harvard nurses health study scrambles to save 50 years of samples
- News
Court victory for Harvard in research funding fight
- Documents